Top Markets
Coin of the day
F-star Therapeutics, Inc. F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTX
Rankning i aktier #21013
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing Phase 1 clinical evaluation for patients with advanced malignancies. Founded in 2002, F-star Therapeutics, Inc. has its corporate headquarters situated in Cambridge, United Kingdom.
Aktiekurs
$7.12
Senast synkroniserad: 2023-03-08
Marknadsvärde
$117.03M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
GB
Handel F-star Therapeutics, Inc. (FSTX)

Kategori

Historik för aktiesplit för F-star Therapeutics, Inc. (FSTX)
Aktien F-star Therapeutics, Inc. (symbol: FSTX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 23, 2026.
En FSTX-aktie köpt före Aug 23, 2026 motsvarar nu 0 FSTX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH